Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where K. Kallianidis is active.

Publication


Featured researches published by K. Kallianidis.


Fertility and Sterility | 1999

Oocyte morphology correlates with embryo quality and pregnancy rate after intracytoplasmic sperm injection

D. Loutradis; P. Drakakis; K. Kallianidis; Spyridon Milingos; Spyridon Dendrinos; S. Michalas

OBJECTIVE To evaluate the relation of oocyte morphology with embryo quality and pregnancy rates (PRs) after intracytoplasmic sperm injection (ICSI). DESIGN Retrospective study of patients undergoing ICSI. SETTING University Hospital IVF Center. PATIENT(S) Sixty-eight patients who underwent ICSI and had transfer of good-quality embryos (grade 3), 60 patients with transfer of both good- and poor-quality embryos (grade 3 and grade 2), and 18 patients with transfer of poor-quality embryos (grade 2). INTERVENTION(S) Comparison of the outcome of ICSI in the three groups of patients and the relation of oocyte morphology to embryo quality. MAIN OUTCOME MEASURE(S) Oocyte morphology and embryo quality (grade). Fertilization, cleavage, and pregnancy rates. Serum E2 on the day of hCG administration. RESULT(S) Oocytes with poor morphology (dark cytoplasm; many vacuoles or fragments in cytoplasm) led to poor-quality embryos and consequently to lower PRs (5.5% versus 29.4%). Serum E2 on the day of hCG administration was significantly higher in the group with good-quality embryos compared with that with poor-quality embryos (2,047 +/- 135.7 versus 1,651 +/- 164.8 pg/mL, respectively). CONCLUSION(S) Serum E2 on the day of hCG administration is a marker of embryo quality. Oocyte morphology correlates well with embryo quality and PRs after ICSI.


Fertility and Sterility | 2001

Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men

D. Loutradis; P. Drakakis; K. Kallianidis; Eleni Patsoula; Ritsa Bletsa; S. Michalas

OBJECTIVE To report two cases of live births after intracytoplasmic sperm injection (ICSI) in two women who were seronegative for human immunodeficiency virus type 1 (HIV-1) after the use of processed semen from their seropositive husbands. DESIGN Case reports. SETTING University hospital IVF center. PATIENT(S) Two HIV-1 seropositive men and their HIV-1 seronegative female partners; all gave their informed consent in writing before undergoing the ICSI procedures. INTERVENTION(S) The men provided semen samples that were processed with the use of Percoll and swim-up techniques. Ovarian stimulation in the women was performed with the long protocol using GnRH analogs and recombinant FSH. ICSI was performed. MAIN OUTCOME MEASURE(S) Oocytes were fertilized by ICSI, and the resulting embryos were transferred to the patients. The mothers and babies were tested for HIV-1 antibodies. RESULT(S) In the first case, seven mature oocytes were collected and fertilized with ICSI, and three embryos were transferred; the woman became pregnant and gave birth to a healthy boy. Six months after the birth, testing for HIV-1 antibodies in the woman and the baby gave negative results. In the second case, 10 mature oocytes were collected and fertilized with ICSI, and four embryos were transferred; the second woman became pregnant and also gave birth to a healthy boy. Testing for HIV-1 antibodies at the babys delivery also gave negative results. CONCLUSION(S) In women who are infertile because of fallopian tube obstruction or in men who have poor quality semen for artificial insemination, ICSI can be performed using processed semen. This method, which involves the use of only one spermatozoon per oocyte, provides HIV-1 seropositive men with the opportunity to have children with a minimal risk-if any-of infecting their female partners.


Annals of the New York Academy of Sciences | 2006

Biological Factors in Culture Media Affecting in Vitro Fertilization, Preimplantation Embryo Development, and Implantation

D. Loutradis; P. Drakakis; K. Kallianidis; N. Sofikitis; G. Kallipolitis; S. Milingos; Nikolaos Makris; S. Michalas

Abstract: Optimal culture conditions are of paramount importance for in vitro fertilization of gametes, preimplantation embryo development, and implantation for all species. Water is the basis of all culture media, and ultrapure water should be employed. The main energy sources of a medium are lactate, pyruvate, and glucose. The concentrations of the first two vary in different media, whereas the latter is necessary mainly for the later stages (morula to blastocyst) of development. A fixed nitrogen source is essential for implantation embryo development whether this is provided by amino acids, albumin, or serum. Suboptimal culture conditions can block development. Pronuclear zygotes of most species (but not human) arrest at some point between the two‐cell and the 16‐cell stage. Modifying culture conditions can lead the embryos to develop through this block. Hypoxanthine also causes a two‐cell block to mouse pronuclear zygotes, and this again depends largely on culture conditions. Simple culture media are bicarbonate‐buffered systems with pyruvate, lactate, and glucose. Complex media, such as Hams F‐10, contain in addition amino acids and other elements found in serum. Human tubal fluid simulates the fallopian tube microenvironment. EDTA, gonadotropins, growth factors, and other substances can be included in the media to stimulate development. Coculture of embryos with oviductal cells has shown promising results.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 1996

Oocyte donation to women over 40 years of age: pregnancy complications

S. Michalas; D. Loutradis; P. Drakakis; S. Milingos; John Papageorgiou; K. Kallianidis; Eugene Koumantakis; D. Aravantinos

Recently, oocyte donation to women of advanced age has led to a considerable number of conceptions, thus increasing the age limit for becoming pregnant. A main consideration encountered by physicians, though, is the potential medical and obstetric complications of a pregnancy at an advanced age. In this study, the obstetric complications, as well as the perinatal outcome, of pregnancies of aged recipients (above 40) are presented and compared to those of younger recipients. A significantly higher incidence of gestational diabetes (P < 0.001), an increased incidence of pre-eclampsia (at the 10% level of significance) and an increased risk for thrombophlebitis (again at the 10% level) was observed in the older patients, but a careful follow-up during their pregnancy led to a highly satisfactory obstetric and perinatal outcome. A rigorous precycle medical screening (especially for cardiovascular diseases and diabetes) and a careful follow-up during pregnancy is, therefore, imperative so that oocyte donation to older women is not withheld and continues to provide fertility possibilities to otherwise sterile patients.


Gynecologic and Obstetric Investigation | 1995

A preliminary study of the effect of growth hormone on mouse preimplantation embryo development in vitro

P. Drakakis; D. Loutradis; S. Milingos; S. Michalas; K. Kallianidis; Ritsa Bletsa; D. Aravantinos; Ann A. Kiessling

The role of growth hormone (GH) in follicular development, ovulation and embryo development is currently under reconsideration. In this study, we have tried to investigate the effect of GH on preimplantation development of mouse embryos in vitro. Zygotes and two-cell mouse embryos were cultured without (control) or with GH. For zygotes, the addition of 0.2 micrograms/ml of GH resulted in 77 +/- 1% of blastocysts formed and 66 +/- 3% rate of hatching (control 64 +/- 4 and 31 +/- 3%, p < 0.05 and p < 0.01, respectively). For two-cell embryos, the addition of 0.2 micrograms/ml of GH resulted in 87 +/- 2% of blastocysts formed and 60 +/- 4% hatching rate (control 76 +/- 4 and 47 +/- 5%, p < 0.05 for both). This positive effect of GH addition implies that the latter can support mouse preimplantation development in vitro and it suggests, along with its local action on the ovary and its possible effects, via the insulin-like growth factor system, on the tubal and uterine epithelium, a continuous role of this hormone in reproductive physiology from follicular maturation to embryonic development and, possibly, implantation.


Journal of Assisted Reproduction and Genetics | 1996

The in vitro development of mouse embryos beyond the blastocyst stage into the hatching and outgrowth stage using different energy sources

P. Drakakis; D. Loutradis; S. Milingos; Ritsa Bletsa; K. Kallianidis; S. Michalas; D. Aravantinos

AbstractPurpose: The purpose of this study was to investigate the effect of male and female serum supplementation on the in vitro development of mouse embryos beyond the blastocyst stage until the outgrowth stage since the latter may be related to the nidation of the embryo. We also studied the effect of EGF addition on embryo culture and blastocyst outgrowth. Methods and Results: The blastocyst and hatching rates of two-cell mouse embryos cultured in Hams F-10+BSA, Hams F-10+male serum, or Hams F-10+female serum were found to be comparable (P>0.05). The outgrowth rate of hatched blastocysts was significantly increased, though, when they were transferred to 50% male serum compared to either 50% BSA or 50% female serum (P<0.01 and P<0.05, respectively). In the last experiment, either 100 or 150 ng/ml EGF was added to the culture medium from the two-cell stage till blastocyst development and the latter were cultured till outgrowth in 50% BSA, male serum, or female serum. For both concentrations of EGF, the outgrowth rate was significantly higher in male serum compared to the other conditions (P<0.01 and P<0.05, respectively). The outgrowth rate was also higher when EGF was used compared to plain medium before transferring the blastocysts to either male or female serum (P<0.01 for both). Conclusions: We conclude that the development of embryos to the outgrowth stage is significantly enhanced by male serum. The addition of EGF from the two-cell stage also significantly improves the outgrowth success rate for both male and female serum conditions.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 1994

The effect of compounds altering the cAMP level on reversing the 2-cell block induced by hypoxanthine in mouse embryos in vitro

D. Loutradis; P. Drakakis; S. Michalas; C. Hatzaki; K. Kallianidis; L. Aravantinos; Ann A. Kiessling

The possibility of reversing the hypoxanthine induced 2-cell block in mouse embryos when cultured in conditions supplemented with compounds that increase (FSH, hMG, IBMX, hCG) or inhibit (GnRH-analogue) cAMP was assessed. When embryos were cultured in Hams F-10 without hypoxanthine supplemented with each of the above compounds, no inhibition of blastocyst development was observed. Embryos were then cultured in Hams F-10 with hypoxanthine supplemented again with each compound. For the addition of GnRH-analogue or FSH, the rate of blastocyst formation was comparable with that of the control medium with hypoxanthine alone. Instead, the addition of IBMX or hMG reversed the induced block. There was no reversible effect for the addition of 2 micrograms/ml hCG while the latter was observed with higher doses. The results from GnRH-analogue and IBMX addition show that, contrary to what was found for oocytes, stimulation of cAMP reverses the hypoxanthine-induced block in mouse embryos. FSH and hCG also had effects opposite to those observed for oocytes. It is unknown why hMG (FSH + LH) reverses the block. A lower cAMP degradation rate resulting in a higher cAMP level is a possible explanation. Our results provide further evidence that cleavage arrest by hypoxanthine has a different mechanism than the hypoxanthine-induced arrest of meiosis.


Human Reproduction | 1991

Preovulatory effects of the progesterone antagonist mifepristone (RU486) in mice

D. Loutradis; R. Bletsa; L. Aravantinos; K. Kallianidis; S. Michalas; A. Psychoyos


Human Reproduction | 1996

A flexible protocol for the induction of recipient endometrial cycles in an oocyte donation programme

S. Michalas; D. Loutradis; P. Drakakis; K. Kallianidis; S. Milingos; E. Deligeoroglou; D. Aravantinos


European Journal of Obstetrics & Gynecology and Reproductive Biology | 1998

The effect of the duration of GnRH-agonist down regulation before ovarian stimulation on the biological and clinical outcome after intracytoplasmic sperm injection

D. Loutradis; P. Drakakis; K. Kallianidis; Ritsa Bletsa; Spiros Milingos; Nikos Makris; S. Michalas

Collaboration


Dive into the K. Kallianidis's collaboration.

Top Co-Authors

Avatar

D. Loutradis

Athens State University

View shared research outputs
Top Co-Authors

Avatar

S. Michalas

Athens State University

View shared research outputs
Top Co-Authors

Avatar

P. Drakakis

Athens State University

View shared research outputs
Top Co-Authors

Avatar

S. Milingos

Athens State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ritsa Bletsa

Athens State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Liapi

Athens State University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge